Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting
Date:
27/02/2013 to 28/02/2013
Location:
European Medicines Agency, London, UK
This is a joint meeting with representatives from patients', consumers' and healthcare professionals' organisations. The participants are discussing issues in relation to their general involvement in the Agency's activities, giving particular focus to the communication on safety referrals and risk communication, the implementation of the new pharmacovigilance legislation and falsified medicines.
-
List item
Agenda - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013 (PDF/166.21 KB)
Draft
First published: 25/02/2013
Last updated: 24/05/2013
EMA/810501/2012 -
List item
Minutes of the Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013 (PDF/189.81 KB)
Adopted
First published: 24/05/2013
Last updated: 24/05/2013
EMA/228576/2013 -
List item
List of participants - Patients' and Consumers' Working Party (PCWP) and Healthcare Professionals' Working Group (HCPWG) joint meeting - February 2013 (PDF/147.95 KB)
First published: 24/05/2013
Last updated: 24/05/2013
EMA/50881/2013 -
List item
Presentation - How we communicate the outcome of safety reviews (Rebecca Harding) (PDF/325.46 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Involvement of patients' and consumers' organisations and healthcare professionals in safety communications (Nathalie Bere, Ivana Silva) (PDF/166.24 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Risk communication in a more transparent regulatory environment (Frederic Bouder) (PDF/295.19 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Transparency and risk communication: Feedback from the Ditchley Group (David H.-U. Haerry) (PDF/157.27 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Focussing on risk communication: Why now? What next? - Global lessons learnt from the Drug Safety theme edition (Priya Bahri) (PDF/330.39 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - European Union regulatory workshop on medication errors (Thomas Goedecke) (PDF/511.3 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Additional monitoring of medicinal products – update of the implementation (Alexios Skarlatos) (PDF/314.12 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Communication of additional monitoring (PDF/168.1 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Feedback from teleconference on handling of conflicts of interest for patients' and consumers' organisations (PDF/148.11 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Involvement of children and young people in the Paediatric Committee activities (Elin Haf Davies) (PDF/847.08 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Scientific advice, protocol assistance and patient representatives (Jane Moseley) (PDF/301.66 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Preparing patients' representatives for protocol assistance (Maria Mavris) (PDF/953.35 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - Proactive publication of clinical-trial data: Feedback from the European Medicines Agency workshop (Francesco Pignatti) (PDF/273.59 KB)
First published: 24/05/2013
Last updated: 24/05/2013 -
List item
Presentation - European Union Clinical Trial Register and EudraCT (Ana Rodriguez) (PDF/413.1 KB)
First published: 24/05/2013
Last updated: 24/05/2013